Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunomodulatory Effects of SGLT2 Inhibitors—Targeting Inflammation and Oxidative Stress in Aging
Ema Schönberger, Vjera Mihaljević, Kristina Steiner, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 17, pp. 6671-6671
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

SGLT2 Inhibitors in Kidney Diseases—A Narrative Review
Agata Gajewska, Jakub Wasiak, Natalia Sapeda, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4959-4959
Open Access | Times Cited: 8
Narrative Review of Immunomodulatory and Anti-inflammatory Effects of Sodium-Glucose Cotransporter 2 Inhibitors: Unveiling Novel Therapeutic Frontiers
Sul A Lee, Leonardo V. Riella
Kidney International Reports (2024) Vol. 9, Iss. 6, pp. 1601-1613
Open Access | Times Cited: 7
The protective effects of liraglutide in reducing lipid droplets accumulation and myocardial fibrosis in diabetic cardiomyopathy
Chien-Yin Kuo, Sing‐Hua Tsou, Edy Kornelius, et al.
Cellular and Molecular Life Sciences (2025) Vol. 82, Iss. 1
Open Access
Based on network pharmacology-molecular docking and experimental exploration, the preventive and therapeutic effects of dapagliflozin on gouty arthritis in rats were investigated
Ye Tao, Jingfang Du, Pian Li, et al.
Research Square (Research Square) (2025)
Closed Access
Neuroprotective effects of empagliflozin against scopolamine-induced memory impairment and oxidative stress in rats
Mahdieh Anoush, Neda Taghaddosi, Zahra Bokaei Hosseini, et al.
IBRO Neuroscience Reports (2025) Vol. 18, pp. 163-170
Open Access
Sex-Specific Improvements in Myocardial Function and Angiogenesis with SGLT-2 Inhibitor Canagliflozin in a Swine Model of Metabolic Syndrome
Dwight D. Harris, Mark Broadwin, Christopher Stone, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1887-1887
Open Access
SGLT2 inhibitors in peritoneal dialysis: a promising frontier toward improved patient outcomes
N. Stepanova
Renal Replacement Therapy (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 4
A review regarding the article ‘Targeting inflammatory signaling pathways with SGLT2 inhibitors: Insights into cardiovascular health and cardiac cell improvement’
Xiaoqin He, Dou Yuan
Current Problems in Cardiology (2024) Vol. 49, Iss. 6, pp. 102563-102563
Closed Access | Times Cited: 4
Novel Therapeutics for Type 2 Diabetes Mellitus—A Look at the Past Decade and a Glimpse into the Future
Ying Jie Chee, Rinkoo Dalan
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1386-1386
Open Access | Times Cited: 4
Anti-Arrhythmic Effects of Heart Failure Guideline-Directed Medical Therapy and Their Role in the Prevention of Sudden Cardiac Death: From Beta-Blockers to Sodium-Glucose Cotransporter 2 Inhibitors and Beyond
Wael Zaher, Domenico G. Della Rocca, Luigi Pannone, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 5, pp. 1316-1316
Open Access | Times Cited: 3
Proximal tubule hypertrophy and hyperfunction: a novel pathophysiological feature in disease states
Mehmet Kanbay, Sidar Çöpür, Mustafa Güldan, et al.
Clinical Kidney Journal (2024) Vol. 17, Iss. 7
Open Access | Times Cited: 3
Empagliflozin-activated AMPK elicits neuroprotective properties in reserpine-induced depression via regulating dynamics of hippocampal autophagy/inflammation and PKCζ-mediated neurogenesis
Radwa N. Muhammad, Mohammed A. Albahairy, Mai A. Abd El Fattah, et al.
Psychopharmacology (2024) Vol. 241, Iss. 12, pp. 2565-2584
Open Access | Times Cited: 3
Proteomic Profiling of SGLT-2 Inhibitor Canagliflozin in a Swine Model of Chronic Myocardial Ischemia
Dwight D. Harris, Sharif A. Sabe, Mark Broadwin, et al.
Biomedicines (2024) Vol. 12, Iss. 3, pp. 588-588
Open Access | Times Cited: 2
SGLT2 inhibitor as a potential therapeutic approach in hyperthyroidism-induced cardiopulmonary injury in rats
Nermeen Bastawy, Aliaa E. M. K. El‐Mosallamy, Samira H. Aljuaydi, et al.
Pflügers Archiv - European Journal of Physiology (2024) Vol. 476, Iss. 7, pp. 1125-1143
Open Access | Times Cited: 2
Pre-procedural Stratification by the Endothelial Function in Patients with Heart Failure Undergoing Atrial Fibrillation Ablation
Akihiro Oka, Yuya Sudo, Takeshi Morimoto, et al.
Hellenic Journal of Cardiology (2024)
Open Access | Times Cited: 1
Evolving Clinical Features of Diabetic Ketoacidosis: The Impact of SGLT2 Inhibitors
Selin Genç, Bahri Evren, Özlem Yiğit, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 11, pp. 1553-1553
Open Access | Times Cited: 1
Effects of Diet-induced Metabolic Syndrome on Cardiac Function and Angiogenesis in Response to Sodium-glucose Cotransporter-2 Inhibitor Canagliflozin
Dwight D. Harris, Mark Broadwin, Sharif A. Sabe, et al.
Journal of Thoracic and Cardiovascular Surgery (2024)
Closed Access | Times Cited: 1
Extrarenal Benefits of SGLT2 Inhibitors in the Treatment of Cardiomyopathies
Veera Ganesh Yerra, Kim A. Connelly
Physiology (2024) Vol. 39, Iss. 6, pp. 412-434
Closed Access | Times Cited: 1
The Potential Impact of SGLT2-I in Diabetic Foot Prevention: Promising Pathophysiologic Implications, State of the Art, and Future Perspectives—A Narrative Review
Giuseppe Miceli, Maria Grazia Basso, Andrea Roberta Pennacchio, et al.
Medicina (2024) Vol. 60, Iss. 11, pp. 1796-1796
Open Access | Times Cited: 1
Blood Pressure Patterns and Hepatosteatosis: Cardiometabolic Risk Assessment in Dipper and Non-Dipper Phenotypes
Ramazan Astan, Dimitrios Patoulias, Ana Ninić, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 22, pp. 6976-6976
Open Access | Times Cited: 1
Adipose tissue as target of environmental toxicants: focus on mitochondrial dysfunction and oxidative inflammation in metabolic dysfunction-associated steatotic liver disease
Bogdan M. Lolescu, Adina V. Furdui-Lința, C. Ilie, et al.
Molecular and Cellular Biochemistry (2024)
Open Access | Times Cited: 1
The Reasons for Low Uptake of New Antidiabetic Drugs with Cardiovascular Effects – a Family Doctor Perspective: Does Limited Applicability of Clinical Guidelines in Real-Life Practice Matter? A Narrative Review
Tomislav Kurevija, Dunja Šojat, Zvonimir Bosnić, et al.
(2024)
Open Access
The Reasons for the Low Uptake of New Antidiabetic Drugs with Cardiovascular Effects—A Family Doctor Perspective
Tomislav Kurevija, Dunja Šojat, Zvonimir Bosnić, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 6, pp. 1617-1617
Open Access
Long-Term Mortality and SGLT2 Inhibitors in Type 2 Diabetes with and without Renal Impairment: An Observational Cohort Study
Abdullah Al‐Muhaiteeb, Barrak Alahmad, Mohamed Abu‐Farha, et al.
Medical Principles and Practice (2024) Vol. 33, Iss. 3, pp. 251-259
Open Access
Could the administration of SGLT2i agents serve as a viable prophylactic approach against CNI-induced toxicities?
Emad Molaei, Ali Molaei, Simin Dashti‐Khavidaki, et al.
Medical Hypotheses (2024) Vol. 189, pp. 111417-111417
Closed Access
Page 1 - Next Page

Scroll to top